This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Ryvu Therapeutics S.a.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Anna Rajda: Innovator in Functionalized Heterocyclic Compounds
Introduction
Anna Rajda is a prominent inventor based in Wroclaw, Poland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the stimulator of interferon genes (STING). Her innovative work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Anna Rajda holds a patent for "Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (STING)." This invention relates to compound-linker constructs and antibody-drug conjugates of compounds that are useful as modulators of STING. The patent highlights her expertise in creating novel compounds that can enhance immune responses.
Career Highlights
Anna is currently employed at Ryvu Therapeutics S.A., a company dedicated to advancing cancer therapies. Her role involves research and development of innovative solutions that can lead to breakthroughs in treatment options. With her extensive knowledge and experience, she plays a crucial part in the company's mission to improve patient outcomes.
Collaborations
Anna collaborates with talented professionals in her field, including Magdalena Izabela Zawadzka and Luigi Piero Stasi. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in drug development.
Conclusion
Anna Rajda is a remarkable inventor whose work in functionalized heterocyclic compounds showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.